Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol KIR3DL2 contributors: mct - updated : 28-06-2013
HGNC name killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
HGNC id 6339
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two tyrosine based inhibitory motifs (ITIM)
  • a 21-amino acid signal peptide
  • an extracellular region containing three C2-type Ig-like domains with 3 potential N-linked glycosylation sites
  • a KIR3DL interaction site seem to be largely conserved across the KIR3D family, with specificity differences mapping to a hotspot within the interaction interface
  • a 20-amino acid hydrophobic transmembrane region
  • and a 95-amino acid cytoplasmic domain
  • mono polymer dimer
    HOMOLOGY
    Homologene
    FAMILY immunoglobulin superfamily
    CATEGORY receptor
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,endoplasmic reticulum ,rough,smooth
    basic FUNCTION
  • inhibiting the activity of NK cells thus preventing cell lysis
  • crucial role of KIR3DL2 in microbial CpG oligodeoxynucleotide-mediated NK responses
  • three domain killer cell immunoglobulin-like receptor incorporating cytoplasmic immunoreceptor tyrosine inhibitory motifs, expressed as a disulphide-bonded dimer
  • KIR3DL2-expressing natural killer (NK) cells and IL17 secreting CD4 T cells have been implicated in the pathogenesis of ankylosing spondylitis
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • natural killer cell receptor cluster FLNKR@
  • disulfide-linked dimer
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacts with certain HLA-A molecules
  • KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility to autism spectrum disorder
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS